skip to main content

Efek konsumsi yoghurt probiotik terhadap kadar low density lipoprotein pada penyandang diabetes mellitus tipe 2

Kartika Yuliani  -  Nutrition Study Program, Faculty of Health, Surabaya Nahdlatul Ulama University, Indonesia
Nyoman Kertia  -  Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Indonesia
*Lily Arsanti Lestari  -  Department of Health Nutrition, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Indonesia
Received: 31 Mar 2019; Published: 6 Feb 2020.

Citation Format:

Background : As one of important markers of cardiovascular complication in patients with type 2 diabetes mellitus, low density lipoprotein (LDL) shall be maintained to be in normal range. Based on previous research, consumption of probiotic yogurt contains Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis is presumed can improve LDL in patients with type 2 diabetes mellitus but the scientific evidence is still few.

Objectives: To investigate the effect of probiotic yogurt on LDL in patients with type 2 diabetes.

Methods: This study was double blinded randomized controlled trial which was conducted on 32 patientss with type 2 diabetes mellitus. Subjects were divided randomly into 2 groups and given 4 weeks intervention. Subjects in control group were given conventional yogurt while subjects in intervention group were given probiotic yogurt contains L. acidophilus LA5 and B. animalis subsp. Lactis Bb12. Food intake data was collected 4 times using 24-hour recall method during intervention period. LDL of subjects was measured before and after intervention.

Results: There was no significant difference between LDL before and after intervention in control group (128 – 148.5 mg/dL) and intervention group (130 – 120.5 mg/dL). Meanwhile, LDL after intervention in control group and intervention group were significantly different (p<0.05). LDL between energy and macronutrients intake categories were not significantly different.

Conclusion: Probiotic yogurt has a better LDL reduction effect in patients with type 2 diabetes mellitus than conventional yogurt, although the reduction is not significant.

Fulltext View|Download
Keywords: type 2 diabetes mellitus; probiotic; yogurt; low density lipoprotein; LDL

Article Metrics:

  1. Bugger H & Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia, 2014; 57(4): 660–671. doi: 10.1007/s00125-014-3171-6
  2. Pistrosch F, Natali A & Hanefeld M. Is hyperglycemia a cardiovascular risk factor?. Diabetes Care, 2011; 34(SUPPL. 2). doi: 10.2337/dc11-s207
  3. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, et al. Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus in Light of Recent Evidence. Circulation, 2015; 132: 691-718
  4. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World Journal of Diabetes, 2015; 6(3): 456–480. doi: 10.4239/wjd.v6.i3.456
  5. Ejtahed HS, Mohtadi-nia J, Homayouni-rad A, Niafar M, Asghari-jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patientss. Nutrition Journal, 2012; 28: 539–543. doi: 10.1016/j.nut.2011.08.013
  6. Rezaei M, Sanagoo A, Jouybari L, Behnampoo N & Kavosi A. The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patientss with Type II Diabetes : A Randomized Controlled Trial. Evidence Based Journal, 2016; 6(4): 25–35. doi: 10.22038/ebcj.2016.7984
  7. Dirienzo DB. Effect of probiotics on biomarkers of cardiovascular disease : implications for heart-healthy diets. Nutrition Reviews, 2013; 72(1): 18–29. doi: 10.1111/nure.12084
  8. Laitinen K, Poussa T, Isolauri E, et al. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. The British journal of nutrition, 2009; 101(11): 1679–87. doi: 10.1017/S0007114508111461
  9. Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proceedings of the National Academy of Sciences, 2014; 111(20): 7421–7426. doi: 10.1073/pnas.1323599111
  10. Perkeni. Pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2015. Jakarta: 2015
  11. Moura CS, Lollo PCB, Morato PN, Esmerino EA, Margalho LP, Santos-junior VA, et al. Assessment of antioxidant activity, lipid profile, general biochemical and immune system responses of Wistar rats fed with dairy dessert containing Lactobacillus acidophilus La-5. Food Research International, 2016; 90: 275–280. doi: 10.1016/j.foodres.2016.10.042
  12. Everard A & Cani PD. Best Practice & Research Clinical Gastroenterology Diabetes , obesity and gut microbiota. Best Practice & Research Clinical Gastroenterology, 2013; 27(1): 73–83. doi: 10.1016/j.bpg.2013.03.007
  13. Ivey KL, Hodgson JM, Kerr DA, Thompson PL, Stojceski B & Prince RL. The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial. Nutrition, Metabolism and Cardiovascular Diseases, 2015; 25(1): 46-51
  14. Singh RK, Chang HW,Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. Journal of translational medicine, 2017; 15(1): 73
  15. Koh A, De Vadder F, Kovatcheva-Datchary P & Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell, 2016; 65(6): 1332-1345
  16. Zhang Q, Wu Y & Fei X. Effect of probiotics on glucose metabolism in patientss with type 2 diabetes mellitus : A meta-analysis of randomized controlled trials. Medicina. Lithuanian University of Health Sciences, 2016; 52(1): 28–34. doi: 10.1016/j.medici.2015.11.008
  17. Shah NJ &Swami OC. Role of Probiotics in Diabetes: a Review of Their Rationale and Efficacy. Diabetes, 2017; 5[1]:104-110
  18. Gill JM & Sattar N. Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit?. The Journal of Clinical Endocrinology & Metabolism, 2011; 96 (7): 2032–2034
  19. Miremadi F, Ayyash M, Sherkat F, & Stojanovska L. Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic Lactobacilli and Bifidobacteria. Journal of Functional Foods, 2014 Jul 1;9:295-305
  20. Chaudhury A, Chitharanjan D, Dendi VSR, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Frontiers in endocrinology, 2017, 8 (6)

Last update: 2021-06-15 03:59:54

No citation recorded.

Last update: 2021-06-15 03:59:54

No citation recorded.